These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33551734)

  • 41. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
    Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
    Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cerebrospinal Fluid Aβ43 Is Reduced in Early-Onset Compared to Late-Onset Alzheimer's Disease, But Has Similar Diagnostic Accuracy to Aβ42.
    Lauridsen C; Sando SB; Møller I; Berge G; Pomary PK; Grøntvedt GR; Salvesen Ø; Bråthen G; White LR
    Front Aging Neurosci; 2017; 9():210. PubMed ID: 28701950
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer's Disease.
    Hansson O; Lehmann S; Otto M; Zetterberg H; Lewczuk P
    Alzheimers Res Ther; 2019 Apr; 11(1):34. PubMed ID: 31010420
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation.
    Renard D; Wacongne A; Ayrignac X; Charif M; Fourcade G; Azakri S; Le Floch A; Bouly S; Marelli C; Arquizan C; Hirtz C; Gabelle A; Thouvenot E; Lehmann S
    J Alzheimers Dis; 2016; 50(3):759-764. PubMed ID: 26757185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Age-Dependent Relationship Between Plasma Aβ40 and Aβ42 and Total Tau Levels in Cognitively Normal Subjects.
    Lue LF; Pai MC; Chen TF; Hu CJ; Huang LK; Lin WC; Wu CC; Jeng JS; Blennow K; Sabbagh MN; Yan SH; Wang PN; Yang SY; Hatsuta H; Morimoto S; Takeda A; Itoh Y; Liu J; Xie H; Chiu MJ
    Front Aging Neurosci; 2019; 11():222. PubMed ID: 31551751
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinic-Based Validation of Cerebrospinal Fluid Biomarkers with Florbetapir PET for Diagnosis of Dementia.
    Álvarez I; Aguilar M; González JM; Ysamat M; Lorenzo-Bosquet C; Alonso A; Tartari JP; Romero S; Diez-Fairen M; Carcel M; Pujalte F; Pastor P
    J Alzheimers Dis; 2018; 61(1):135-143. PubMed ID: 29154286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition.
    Risacher SL; Fandos N; Romero J; Sherriff I; Pesini P; Saykin AJ; Apostolova LG
    Alzheimers Dement (Amst); 2019 Dec; 11():510-519. PubMed ID: 31384662
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease.
    Janelidze S; Hertze J; Zetterberg H; Landqvist Waldö M; Santillo A; Blennow K; Hansson O
    Ann Clin Transl Neurol; 2016 Jan; 3(1):12-20. PubMed ID: 26783546
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer's disease dementia in mild cognitive impairment.
    Baldeiras I; Santana I; Leitão MJ; Gens H; Pascoal R; Tábuas-Pereira M; Beato-Coelho J; Duro D; Almeida MR; Oliveira CR
    Alzheimers Res Ther; 2018 Mar; 10(1):33. PubMed ID: 29558986
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Associations of plasma soluble CD22 levels with brain amyloid burden and cognitive decline in Alzheimer's disease.
    Bu XL; Sun PY; Fan DY; Wang J; Sun HL; Cheng Y; Zeng GH; Chen DW; Li HY; Yi X; Shen YY; Miles LA; Maruff P; Gu BJ; Fowler CJ; Masters CL; Wang YJ
    Sci Adv; 2022 Apr; 8(13):eabm5667. PubMed ID: 35363517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiplex immunoassay measurement of amyloid-β
    Vogelgsang J; Shahpasand-Kroner H; Vogelgsang R; Streit F; Vukovich R; Wiltfang J
    Exp Brain Res; 2018 May; 236(5):1241-1250. PubMed ID: 29480353
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease.
    Henjum K; Almdahl IS; Årskog V; Minthon L; Hansson O; Fladby T; Nilsson LN
    Alzheimers Res Ther; 2016 Apr; 8(1):17. PubMed ID: 27121148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hypocretin and brain β-amyloid peptide interactions in cognitive disorders and narcolepsy.
    Dauvilliers YA; Lehmann S; Jaussent I; Gabelle A
    Front Aging Neurosci; 2014; 6():119. PubMed ID: 24966833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biomarkers of neuronal injury and amyloid metabolism in the cerebrospinal fluid of patients infected with HIV-1 subtypes B and C.
    de Almeida SM; Ribeiro CE; Rotta I; Piovesan M; Tang B; Vaida F; Raboni SM; Letendre S; Potter M; Batistela Fernandes MS; Ellis RJ;
    J Neurovirol; 2018 Feb; 24(1):28-40. PubMed ID: 29063514
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Levels of amyloid-beta-42 and CSF pressure are directly related in patients with Alzheimer's disease.
    Schirinzi T; Di Lazzaro G; Sancesario GM; Colona VL; Scaricamazza E; Mercuri NB; Martorana A; Sancesario G
    J Neural Transm (Vienna); 2017 Dec; 124(12):1621-1625. PubMed ID: 28866757
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alzheimer's Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus.
    Mazzeo S; Emiliani F; Bagnoli S; Padiglioni S; Del Re LM; Giacomucci G; Balestrini J; Ingannato A; Moschini V; Morinelli C; Galdo G; Polito C; Ferrari C; Pansini G; Della Puppa A; Sorbi S; Nacmias B; Bessi V
    J Pers Med; 2022 Jun; 12(6):. PubMed ID: 35743720
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebrospinal Fluid Aβ40 Improves the Interpretation of Aβ42 Concentration for Diagnosing Alzheimer's Disease.
    Dorey A; Perret-Liaudet A; Tholance Y; Fourier A; Quadrio I
    Front Neurol; 2015; 6():247. PubMed ID: 26640457
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40.
    Wisch JK; Gordon BA; Boerwinkle AH; Luckett PH; Bollinger JG; Ovod V; Li Y; Henson RL; West T; Meyer MR; Kirmess KM; Benzinger TLS; Fagan AM; Morris JC; Bateman RJ; Ances BM; Schindler SE
    Alzheimers Dement (Amst); 2023; 15(1):e12405. PubMed ID: 36874595
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease.
    Biscetti L; Salvadori N; Farotti L; Cataldi S; Eusebi P; Paciotti S; Parnetti L
    Clin Chim Acta; 2019 Jul; 494():71-73. PubMed ID: 30844364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.